ATLAS CAPITAL ADVISORS INC.
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1434165
JACKSON, WY
Position in REGN
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$5,994,140
+$5,974 QoQ
Shares Held
7,758
0.0% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
1.42%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ATLAS CAPITAL ADVISORS INC. holds $1,601,611 across 7 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
4,983 | $1,200,753 | |
| 2 | RPRX |
Royalty Pharma plc
|
5,727 | $321,112 | |
| 3 | INCY |
Incyte Corp
|
351 | $39,789 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
60 | $29,803 | |
| 5 | ARVN |
Arvinas, Inc.
|
655 | $5,443 | |
| 6 | NKTR |
Nektar Therapeutics
|
40 | $2,792 | |
| 7 | INSM |
INSMED Inc
|
18 | $1,919 |
All Filings in REGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,994,140 | 7,758 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $5,988,166 | 7,758 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $4,072,950 | 7,758 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,364,316 | 8,458 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $6,030,585 | 8,466 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $155,583 | 148 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $8,914,836 | 8,482 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $145,335 | 151 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $7,452,289 | 8,485 | Shares | Sole | 2024-02-15 | |
| 2023-09-30 | $6,982,815 | 8,485 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $6,096,811 | 8,485 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $6,973,513 | 8,487 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $6,123,285 | 8,487 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $5,846,439 | 8,487 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $5,025,787 | 8,502 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $5,923,998 | 8,482 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $5,350,868 | 8,473 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $5,127,690 | 8,473 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $4,732,509 | 8,473 | Shares | Sole | 2021-07-30 | |
| 2021-03-31 | $4,008,915 | 8,473 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $4,236,391 | 8,769 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $5,099,036 | 9,109 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $5,350,293 | 8,579 | Shares | Sole | 2020-07-28 | |
| 2020-03-31 | $4,129,956 | 8,458 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||